Posts

Showing posts with the label sun pharma

Sensex slips 500 points lower, Nifty below 24,550; bank, auto stocks drag

Image
[hfe_template id='11223'] [ad_1] Domestic benchmark indices opened lower on Thursday, dragged by losses in banking and auto stocks, after a strong rally earlier this week that took them to nearly seven-month highs. Analysts expect consolidation as recent gains from trade deal progress and macroeconomic stability appear to be priced in. At around 9:47 am, the BSE Sensex was down 501 points, or 0.62%, at 80,828, while the Nifty50 slipped 131 points, or 0.53%, to 24,535. From the Sensex pack, IndusInd Bank, Sun Pharma, M&M, Maruti, Kotak Bank, and Axis Bank were among the top laggards in early trade, while Tech Mahindra, Adani Ports, Tata Motors, and HCL Tech opened with gains. Among individual stocks, Tata Power jumped 2% after the company reported a 25% YoY increase in its consolidated net profit, reaching Rs 1,306 crore in Q4FY25. Eicher Motors shares surged 2% after the company posted a strong set of Q4FY25 numbers, with consolidated net profit rising 27% year-on-ye...

TCS shares under pressure after weak Q4 results, target price cuts. Should you buy, sell or hold?

Image
[hfe_template id='11223'] [ad_1] Shares of Tata Consultancy Services (TCS) on Friday dropped 1% to Rs 3,212.10 on the BSE after the IT major reported a weaker-than-expected Q4 performance. Consolidated net profit for Q4FY25 declined 1.7% year-on-year to Rs 12,224 crore, falling short of the analysts’ estimate of Rs 12,650 crore. In the year-ago quarter, the net profit was Rs 12,434 crore. Revenue from operations rose 5.3% YoY to Rs 64,479 crore, also missing the ET NOW poll estimate of Rs 64,856 crore. Should you buy, sell, or hold TCS' stock? Here's what analysts say: Centrum Centrum upgraded TCS to ‘Buy’ with a revised target price of Rs 4,211 (down from Rs 4,589), valuing the stock at 25x FY27E EPS. While it flagged muted near-term demand due to macro and geopolitical uncertainties and slower client decision-making, it pointed to strong GenAI deal momentum as a key positive. Centrum sees margin tailwinds from better utilisation, pyramid optimisation, automatio...

Tech, auto heavyweights drag Sensex 200 points lower; Nifty below 23,600

Image
[hfe_template id='11223'] [ad_1] Indian benchmark equity indices Sensex and Nifty50 traded lower on Friday led by losses in M&M and Infosys. However, markets may see intraday fluctuations amid foreign inflows and optimism over a domestic growth rebound. The BSE Sensex was trading 256 points, or 0.33%, lower at 77,361. The Nifty50 was up 67 points, or 0.27%, trading at 23,524 around 9:38 am. Foreign portfolio investors (FPIs) bought Indian shares worth Rs 11,111 crore on Thursday, the highest for a day in six months, provisional data showed. FPIs have been buying in India for six straight sessions after an intense sell-off from late September 2024 when benchmark indices hit lifetime highs. From the Sensex pack, M&M, Infosys, Power Grid, Sun Pharma, HCL Tech, and TCS were the top laggards, declining up to 3.5%. On the other hand, HUL, Nestle India, Kotak Bank, Tata Motors, Asian Paints, and Tata Steel opened with gains. Live Events Among individual stocks, BSE Ltd....

Stocks in news: M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma

Image
[hfe_template id='11223'] [ad_1] The new expiry series began on a weak note, with markets slipping nearly two percent, weighed down by weak global cues. In today's trade, shares of M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma among others will be in focus due to various news developments. M&M Mahindra & Mahindra is working to scale up some of its smaller businesses to match its portfolio of multiple large companies, the top executive at the tractor-to-technology group told ET. Glenmark Pharma Glenmark Pharma is recalling close to 1.5 million bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the US health regulator. Maruti, Hyundai, Tata Motors Maruti Suzuki reported marginal growth while Hyundai and Tata Motors posted a decline in their sales in February as a slowdown in the market continued with demand remaining muted. Indian Overseas Bank Stock Trading Maximise Returns ...

Stocks to buy post Budget 2025: UPL, Sun Pharma among top 5 stocks to buy that could give 14-37% return - Brokerage Recommendations

Image
[hfe_template id='11223'] [ad_1] 1 / 6 Brokerage Recommendations Leading brokerages have shared their latest stock recommendations, reflecting varied outlooks across key sectors for the next 12 months. Motilal Oswal has issued a "Buy" rating on Five-Star Business with a 25% upside potential, while Emkay remains bullish on Sun Pharma, projecting a robust 37% upside. Investec has upgraded UPL to a "Buy," citing operational improvements, and Jefferies continues to favor ITC with a stable outlook supported by taxation benefits. Meanwhile, JPMorgan maintains a "Neutral" stance on ONGC, noting near-term growth drivers alongside production concerns. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Agencies 2 / 6 Motilal Oswal on Five-Star Business Buy | Target Rs 930 | LTP Rs 743 | Upside 25% Motilal Oswal has given a "Buy" rating on Five-Star Business with a target price of Rs 930, indicat...

Stocks to buy today: Sun Pharma, Lupin among top 6 trading ideas for 27 December 2024

Image
[hfe_template id='11223'] [ad_1] The Indian market is likely to trade higher on Friday, tracking positive global cues. The Nifty futures closed in the negative with losses of 0.09%, at the 23,748 levels on Thursday. On the options front, the maximum Call OI is placed at 24,000, followed by the 25,000 strikes, while the maximum Put OI is placed at 23,800, followed by the 23,000 strikes. Call writing is seen at 23,800 and then at the 24,000 strikes, while Put writing is seen at 23,800 and then at the 23,000 strikes. “Options data suggests a broader trading range between the 23,200 to 24,200 zones, with an immediate range between the 23,500 to 23,900 levels,” said Chandan Taparia, Head of Equity Derivatives & Technicals at Wealth Management, MOFSL. “Nifty formed a Doji-like candle on the daily chart on Thursday, showing multiple Dojis, which indicates indecisiveness. A lack of follow-up buying is preventing the index from making any significant movement,” he said.“Now, ...

Sensex rejig in December: Zomato to see $513 million inflows amid shake-up for 6 stocks!

Image
[hfe_template id='11223'] [ad_1] The BSE Sensex undergoes its periodic rebalancing on December 23, to reflect India’s evolving market dynamics. Food delivery firm Zomato replaces steel giant JSW Steel in the 30-share benchmark index. This reshuffle is set to drive $513 million in inflows into Zomato, while JSW Steel faces $252 million in outflows as institutional investors adjust portfolios, according to estimates by brokerage firm Nuvama. Here is a list of 6 stocks undergoing the Sensex reshuffle: Zomato Zomato’s inclusion in the Sensex sheds light on the rising prominence of tech-driven companies. The stock is set to receive inflows of $513 million, with an average volume impact of 2.6x, according to brokerage firm Nuvama. Zomato has seen its share price climb 126% over the past year and with its value growing to a market capitalization of Rs 2.72 lakh crore. JSW Steel JSW Steel will exit the Sensex, resulting in an estimated $252 million in outflows and an average vol...

How to build a resilient portfolio to achieve sustainable growth

Image
[hfe_template id='11223'] [ad_1] “A calm sea doesn't make a skilled sailor " This age-old wisdom holds true in Investing, where skills of an investor are often tested by the lashings of market volatility and other unpredictable and uncertain macroeconomic developments at a global scale. Given the turbulence periodically cropping up in global and domestic markets, it becomes critical for retail investors to start constructing a resilient portfolio. Thorough research and a strategic approach to diversification are essential for navigating such volatility and achieving sustainable growth in their portfolios. Take, for example, the COVID-19 pandemic, which created unprecedented market disruptions, shaking global markets and exposing vulnerabilities in many portfolios. During this crisis, sectors like travel and hospitality were hit hard, while technology and pharmaceuticals thrived. Investors who had diversified their portfolios, with a mix of stable fundamentally s...

sensex news: Sensex, Nifty off to a choppy start tracking global peers; all eyes on Powell speech

Image
[hfe_template id='11223'] [ad_1] Domestic equity indices Sensex and Nifty opened flat on Friday, reflecting a pause in the global equities rally ahead of the Federal Reserve Chair Jerome Powell's address later today, as markets await confirmation of U.S. rate cuts starting in September. The BSE Sensex was trading 42 points, or 0.05%, lower at 81,009. The Nifty50 was down 7 points, or 0.03%, trading at 24,803 around 9:19 am. Wall Street shares closed lower overnight, as sentiment turned cautious ahead of Fed Chair Jerome Powell's speech in Jackson Hole after Indian market hours on Friday. Among Sensex stocks, Tata Motors, Reliance Industries, Sun Pharma, HUL, M&M, and Power Grid opened higher, while Infosys, Tech Mahindra, Titan, NTPC, and Tata Steel opened lower. Sector-wise, Nifty IT dropped 0.75%, weighed down by Mphasis, Persistent Systems, and LTIMindtree. Nifty Banks, Financials, FMCG, Media, Metal, Realty, and Consumer Durables also opened lower, while ...

Avoid aggressive bets as markets may see volatility spike

Image
[hfe_template id='11223'] [ad_1] Technical analysts advise avoiding aggressive bets until global market conditions stabilise. If Nifty stays below 24,800 and VIX remains above 14.5%, a correction is likely, with key support at 24,540 and 24,210. Stocks like Nykaa, HDFC Bank, Sun Pharma, TCS, GAIL, Adani Ports, ITC, Chambal Fertilisers, KNR Construction, Oil India, and CESC look promising, according to technical charts. SAMEET CHAVAN, HEAD RESEARCH TECHNICAL AND DERIVATIVES, ANGEL ONE Where is Nifty headed this week? There have been insignificant alterations to the price action for Nifty, though the overall market breadth turned a bit exhaustive, indicating a sign of caution. From a technical standpoint, the Nifty index continues to maintain a position above all its major EMAs, with robust nearby support identified around 24,600-24,500. Also, till Nifty remains above this level, there shouldn’t be any significant cause for concern. However, the bearish gap on the daily ch...

Q1 results today: ITC, Tata Motors among 88 companies will announce earnings on Thursday

Image
[hfe_template id='11223'] [ad_1] The first quarter earnings season is underway and as many as 88 companies will announce their quarterly numbers on Thursday. Key results to watch out for include ITC, Sun Pharma, Tata Motors, Adani Enterprises, Adani Ports, Zomato and Dabur. Apart from the above, companies like AB Capital, Clean Science Tech, Emami, Escorts Kubota, Indegene, Le Travenues Technology, Max Healthcare, RailTel Corp, Tube Investments among others will also declare June quarter results. ITC Q1 expectations Diversified conglomerate ITC Ltd is expected to see a healthy revenue growth during the first quarter ended June 2024, led by cigarettes and hotels businesses.Revenue for the April-June 2024 period is seen growing 6% year-on-year, according to an average estimate of four brokerages. Meanwhile, net profit is likely to rise 3% year-on-year for the reporting period. While the cigarettes, hotels and FMCG businesses are estimated to report decent growth during the...